Buy AOD-9604 Research Peptide

Further structural refinement of the growth hormone C-terminal fragment produced AOD-9604, a compound generating a distinct research trajectory within GH-derived peptide pharmacology. Also known as Advanced Obesity Drug 9604 (CAS 221231-10-3), carries the molecular formula C78H123N23O23S2 and a molecular weight of 1815.13 g/mol. AOD-9604 is derived from the same C-terminal GH region as Fragment 176-191 and has been studied as a structurally related analogue within the same lipolytic research context. Produced via solid-phase peptide synthesis.

In vitro studies using 3T3-L1 preadipocyte differentiation models have examined the compound's influence on lipolytic enzyme expression and lipogenic transcription factor activity. In vivo rodent studies have characterised the comparative pharmacokinetic profiles of AOD-9604 and unmodified HGH Frag 176-191.

Manufactured in a quality-controlled laboratory to a guaranteed purity of 98% or above. Every batch undergoes independent third-party testing using HPLC and MS-UPLC analysis before dispatch. Vials are vacuum sealed and stored in a temperature-controlled, monitored cold storage system. A batch-specific Certificate of Analysis is available on request.

Sold strictly for in vitro research purposes only. Not for human consumption. Intended for use by qualified researchers in laboratory settings only.